哈藥股份(600664.SH):法院對GNC重整事宜舉行聽證會 批准哈藥集團簽署的相關交易文件
格隆匯9月21日丨哈藥股份(600664.SH)公佈,公司於2020年9月21日接到公司控股股東哈藥集團有限公司(以下簡稱“哈藥集團”)的通知,美國東部時間2020年9月17日,特拉華州美國破產法院(以下簡稱“法院”)對GNC Holdings Inc.(以下簡稱“GNC”)重整事宜舉行聽證會,並於美國東部時間2020年9月18日公佈正式的判決結果批准哈藥集團與相關方簽署的Stalking Horse Agreement及其他交易文件,並批准、授權相關方按照該等交易文件推進GNC出售計劃。該事項後續還需要在美國高等法院(擬定於9月22日)舉行的聽證會上確認GNC債權人權利的分配。
公司已在2020年6月24日披露的《關於GNC相關事宜的公告》中將上述事項對公司可能的影響進行了説明。公司將根據擬定於9月22日聽證會的結果判斷該事項對公司前期認購GNC可轉換優先股事宜的最終具體影響。公司董事會及管理層將持續關注GNC後續進展,並敦促哈藥集團及公司委派到GNC的董事及時瞭解事態進展,及時評估對公司的具體影響並履行信息披露義務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.